Related Experiment Video
Updated: May 28, 2026

05:27
Stromal Cell Isolation From Hematopoietic Organs
Published on: January 26, 2024
Age-related changes in rat bone-marrow mesenchymal stem cell plasticity.
Faizal Z Asumda1, P Bryant Chase
1Institute of Molecular Biophysics, Florida State University, Tallahassee, FL, USA.
BMC Cell Biology
|October 14, 2011
Summary
Aging impairs bone marrow-derived mesenchymal stem cells (BM-MSCs), reducing their stemness markers and differentiation potential. This age-related decline may limit the effectiveness of autologous stem cell therapy in elderly patients.
Area of Science:
- Gerontology
- Stem Cell Biology
- Regenerative Medicine
Background:
- The efficacy of adult stem cells diminishes with age, raising concerns for autologous cell therapy in elderly individuals.
- Age-related decline in stem cell function impacts therapeutic potential.
Purpose of the Study:
- To investigate age-related alterations in bone marrow-derived mesenchymal stem cells (BM-MSCs) from rats.
- To assess the impact of aging on BM-MSC stemness, differentiation, and therapeutic potential.
Main Methods:
- Compared BM-MSCs from young (4-month-old) and old (15-month-old) rats.
- Analyzed stemness marker expression (Oct-4, Sox-2, NANOG).
- Assessed differentiation potential (chondrogenic, osteogenic, adipogenic, cardiomyogenesis) and gene/protein expression (connexin-43, VEGF, IGF, EGF, G-CSF, γ-H2AX, telomerase activity).
Main Results:
- Old BM-MSCs showed altered stemness marker expression, lacking Sox-2 and NANOG.
- Differentiation potential (chondrogenic, osteogenic, adipogenic) was compromised in old BM-MSCs.
- Old BM-MSCs exhibited reduced cardiomyogenesis, altered connexin-43 expression, lower growth factor levels, increased DNA damage (γ-H2AX), and diminished telomerase activity compared to young BM-MSCs.
Conclusions:
- Age-related changes in BM-MSCs significantly affect their differentiation capacity.
- These alterations may compromise the efficacy of BM-MSCs in autologous stem cell therapy for older patients.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

